Pfizer Inc. (NYSE:PFE) has recently launched a multi-year cost reduction initiative aimed at saving approximately $1.5 ...
Pfizer has said it will shed staff and cut its operating costs by around $3.5 billion, as it faces a shortfall in COVID-19 vaccine and treatment sales, with revenues now expected to be down around ...
Pfizer has unveiled plans to cut 500 jobs at its laboratories in Kent as it races to strip $3.5bn (£2.8bn) worth of costs out in the face ... wide cost realignment program. Various areas of ...
Pfizer, which is going through a cost-cutting program after misreading future sales of its Covid products, said patients will have access to same-day appointments with independent healthcare ...
Pfizer has fleshed out some more of the details of its wide-ranging cost-cutting drive announced last month, revealing that around 500 jobs will go in the UK, including at its R&D site at Sandwich ...
Moderna shares have dropped by over -41.67% since I last covered them over the summer. See why I continue to rate MRNA stock ...
But those days are over, and many pharma companies are looking to cut costs as they contend with a slowdown. While many companies, from Pfizer to Bristol-Myers Squibb to Bayer and Novartis ...
The Supplemental Nutrition Assistance Program (SNAP) is America’s first line of defense against hunger, provides significant cost savings for health ... When they run out, that’s it.” Any cut to SNAP ...
Pfizer Inc.’s stock rose 2.7% early Tuesday, after the company blew past earnings estimates for the second quarter, offered an update on a cost-cutting ... optimization program, EPS came to ...
Pfizer and Moderna stocks are breaking out to the upside. Here's how to trade both names now, even as the market swoons. Shares of Moderna are now up more than 78% from the low they made in October.
Is laying off 17% of its staff and ending its $80 million J.P. Morgan-backed programs at the ... in its workforce as it rolls out a broader effort to cut costs and streamline its operations.